过去一年，得益于突破性创新以及纳斯达克生物科技股票交易数量的增加，纳斯达克生物科技指数（NASDAQ Biotechnology Index, ...

Forward-looking information in this news release includes, but is not limited to, statements regarding the Company’s anticipated inclusion in the Nasdaq Biotechnology Index following the annual ...

The Nasdaq Biotechnology Index contains securities of Nasdaq-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals. The Nasdaq ...

NASDAQ Biotechnology Index4,375.13‎-0.55% 为您推荐 贵州茅台 600519 上证指数 000001 方大特钢 600507 黄金 Gold 深证成指 ...

today announced that it will be added to the Nasdaq Biotechnology Index (NBI), effective at market open on Monday, December 23, 2024. “2024 has been a transformational year for MindMed.

has been selected to join the Nasdaq Biotechnology Index (NBI). The inclusion will be effective from the start of trading on December 23, 2024. The company, currently valued at approximately $530 ...

today announced that it will be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) effective prior to the market open on Monday, December 23, 2024. "Our addition to the NBI is an important ...

will be included in the Nasdaq Biotechnology Index (NASDAQ:NBI) starting Monday, December 23, 2024. Despite an 8% decline over the past week, the stock has shown resilience with a 34% gain over ...

today announced its upcoming addition to the Nasdaq Biotechnology Index (Nasdaq: NBI) as part of the annual reconstitution of the 2024 Nasdaq index. Mesoblast's inclusion in the NBI will be effective ...

(NASDAQ:MNMD), a biopharmaceutical company focused on developing treatments for brain health disorders, has been selected to join the Nasdaq Biotechnology Index (NBI). The inclusion will be effective ...

today announced its upcoming addition to the Nasdaq Biotechnology Index (Nasdaq: NBI) as part of the annual reconstitution of the 2024 Nasdaq index. Mesoblast’s inclusion in the NBI will be effective ...

GAITHERSBURG, Md. - Altimmune, Inc. (NASDAQ:ALT), a clinical-stage biopharmaceutical company trading at $7.90 per share, will be included in the Nasdaq Biotechnology Index (NASDAQ:NBI) starting Monday ...